Particulars |
|
|
|
Company Name
| Aurobindo Pharma Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
350.50 |
Sales(₹ Cr.) |
10,788.09 |
NP (₹ Cr.) |
1,746.79 |
NP Var (%) |
-11.00 |
Div% |
0.00 |
CPS(₹) |
34.90 |
EPS (₹) |
29.80 |
Traded Value(₹ Lakhs) |
765.74 |
52 Week High |
1,593.00 |
52 Week Low |
994.00 |
Price BSE |
1,135.00 |
Price NSE |
1,135.00 |
Market Capital (₹ Cr.) |
66,509.89 |
P/C Ratio |
32.50 |
P/E Ratio |
38.10 |
Price Vs.BV |
3.24 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
2,721.43 |
NP(₹ Cr.) |
408.17 |
NP Var % |
-29.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
10,713.37 |
OPM |
23.11 |
NP |
2,069.02 |
NP Var (%) |
-10.56 |
EPS |
29.81 |
PE |
38.08 |
|
|